This listing includes accelerated approvals (AAs) for non-malignant hematological, neurological, and other disorder indications with postmarketing trials that have been subsequently withdrawn, and are therefore, no longer FDA-approved.
Similar Posts
LLK Trading Inc. Recalls “Needle Mushrooms” Because of Possible Health Risk
LLK TRADING INC. of Linden, NJ, is recalling its 200g packages of “Needle Mushrooms” because it has the potential to be contaminated with Listeria monocytogenesInformation by Drug Class
FDA provides consumers and industry with safety, regulatory and availability information for various drugs by drug class. From A to Z. Topics include: acetaminophen, estrogen, insulin, opioids, statins, and weight-loss drugs.Blue Bell Ice Cream Issues Allergy Alert on Undeclared Almond, Walnut, and Pecan in Moo-llennium Crunch Ice Cream Packaged in a Chocolate Chip Cookie Dough Half Gallon Carton with a Moo-llennium Crunch Ice Cream Lid
BRENHAM, Texas, August 22, 2025 – Blue Bell Ice Cream is voluntarily recalling a limited quantity of Moo-llennium Crunch Ice Cream half gallon packaged in a Chocolate Chip Cookie Dough carton produced in its Brenham, Texas, plant because of undeclared almond, walnut, and pecan. The recalled productNATCO Pharma Limited – 6/19/2025
NATCO Pharma Limited – 6/19/2025. Country: India. Record Type: 483Pine Pharmaceuticals LLC. Tonawanda, NY. 483 issued 11/14/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/14/2025
Short Title (70 char) Pine Pharmaceuticals LLC. Tonawanda, NY. 483 issued 11/14/2025
FEI Number 3010943533
Firm Name Pine Pharmaceuticals LLC
Record Type 483
State NY
Establishment TypeEarly Alert: Stent and Electrocautery-Enhanced Delivery System Issue from Boston Scientific
Boston Scientific is removing certain stents and delivery systems due to issues with deployment and expansion.